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Neurogenesis from Sox2 expressing 
cells in the adult cerebellar cortex
Julia Ahlfeld1,2, Severin Filser3,4, Felix Schmidt1, Annika K. Wefers5, Daniel J. Merk6,7, Rainer 
Glaß8, Jochen Herms2,4 & Ulrich Schüller1,9,10,11
We identified a rare undifferentiated cell population that is intermingled with the Bergmann glia of the 
adult murine cerebellar cortex, expresses the stem cell markers Sox2 and Nestin, and lacks markers of 
glial or neuronal differentiation. Interestingly, such Sox2+ S100− cells of the adult cerebellum expanded 
after adequate physiological stimuli in mice (exercise), and Sox2+ precursors acquired positivity for 
the neuronal marker NeuN over time and integrated into cellular networks. In human patients, SOX2+ 
S100− cells similarly increased in number after relevant pathological insults (infarcts), suggesting a 
similar expansion of cells that lack terminal glial differentiation.
Neurogenesis within the adult mammalian brain is traditionally said to be restricted to a few discrete niches1, 
many of which are known to bear precursor cells that express the transcription factor Sox22, 3. Attempts have 
been made to identify stem cell populations within the adult cerebellum. It has been shown that there is a distinct 
population of cells within the adult cerebellum that express stem cell markers and that can give rise to neuronal 
progeny when expanded in vitro and subsequently transplanted back into the murine cerebellum4, 5.
Results and Discussion
To identify potential stem cell niches within the adult cerebellum, we carefully investigated the expression pat-
tern of Sox2. As previously described, we found Sox2 expression in a variety of differentiated glia cells, such as 
Bergmann glia cells that are intermingled with the Purkinje cells6 (Fig. 1a and b). However, apart from Bergmann 
glia cells that are characterized by the co-expression of differentiation markers like S100B, Blbp and Gfap, we 
found a subset of Sox2-expressing cells in the Purkinje cell layer (PCL) that lack expression of S100, i.e. Sox2+ 
S100− cells that makes up 18.4% of the entire Sox2+ population within the PCL (Fig. 1c–e). We further found 
Sox2+ cells that co-express Nestin as shown by Nestin-dependent GFP expression (Fig. 1f–h). To validate 
our findings, we checked whether there are other markers of cellular differentiation that would label 100% of 
Bergmann glia cells and consistently found cells that lack expression of Gfap, Blbp, Olig2, Parvalbumin, and Pax2 
(Fig. 1i–w). We speculate that there may be a Sox2+ population that expresses no other marker of cellular differ-
entiation, but further stainings of multiple markers will be necessary to prove this finding. Finally, Sox2 is absent 
from any granule cells that are clearly marked by NeuN7 (Supplementary Figure 1). Triple labelling revealed that 
61.4% of Sox2+ Blbp− cells express the stem cell marker Nestin, (Fig. 2a–c; quantification on n = 4 animals; at 
least 5 sections per cerebellum) and that Sox2+ Nestin+ cells also exhibit proliferative activity (Fig. 2d–f). When 
exposing mice to a physical activity paradigm that is commonly used to determine motor defects in research 
of Parkinson’s disease (RotaRod), we observed a more than 2-fold increase in the number of Sox2+ S100− cells 
within the PCL (Fig. 2j–l), as compared to untrained mice (p = 0.036; Fig. 2g–i, m). This population may there-
fore have reactive properties that can be triggered by physical exercise. Such SOX2+ S100− cells are similarly 
detectable in the human cerebellum (Fig. 3a–d). Notably, perilesional areas in patients, who suffered from a 
cerebellar infarct, contained significantly more SOX2+ S100− cells than the PCL of control tissue (91.7 cells/mm2 
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Figure 1. Presence and expansion of undifferentiated Sox2+ cells in the cortex of the adult murine cerebellum. 
Within the adult cerebellar cortex, Sox2 is expressed in small cells within the Purkinje cell layer (PCL) that were 
believed to represent the Bergmann glia (a and arrows in b). While most of the Sox2 expressing cells within the 
PCL stained positive for the glial marker S100B (arrowheads in c–h), some of them exclusively expressed Sox2 
(arrows in c–e). This population was further characterized by Nestin expression, as detected by Nestin-dependent 
GFP expression (arrows in f–h). Cre as nuclear surrogate for GFAP (arrowheads in i–k) and Blbp (arrowheads in 
l–n) mark Bergmann glia cells, but Sox2+  cells were consistently found that do not co-label with another (single) 
marker, of differentiation (arrows in i–n). Characterization of Sox2-expressing cells within the PCL was done 
by additional staining for specific cerebellar cell types. Sox2+ cells do not express markers of oligodendrocyte 
lineage (Olig2, arrows in o–q) or cerebellar interneurons (Parvalbumin, arrows in r–t and Pax2, arrows in u–w). 
Imunohistochemical stainings were performed on 4 µm FFPE sections. White lines show perimeter of Purkinje cell 
layer. Scale bar in panel a equates to 500 µm, bar in panel b to 50 µm. Scale bars in panels c - w equate to 15 μm.
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(31.1%; SOX2+ S100− cells/total SOX2+ cells) vs. 49.2 cells/mm2 (16.3%; SOX2+ S100− cells/total SOX2+ cells); 
p = 0.0018; Fig. 3e–i), while healthy regions adjacent to infarcts maintained the number of SOX2+ S100− cells 
that was also found in healthy control cerebella (49.5 cells/mm2 (17.1%; SOX2+ S100− cells/total SOX2+ cells)), 
suggesting that reactive properties of these cells may as well be triggered by pathological events.
To examine whether Sox2+ cells produce any progeny at all within the adult cerebellum under physiological 
conditions, we injected 2-month-old Sox2-creERT2::tdTomato mice with Tamoxifen for 8 days and BrdU for the 
final overlapping 7 days and sacrificed them 5 days after the last injections. The Tamoxifen course was started 
one day prior to the BrdU course because of the different kinetics of the two systems. BrdU will be detectable in 
proliferating cells within a few hours after injection. Tamoxifen however, has to be taken up by the cell, dimerized 
and translocated to the nucleus, where transcription and translation of RFP have to be initiated. Subsequent 
triple labelling with antibodies against RFP for lineage tracing, BrdU for proliferation since the day of injec-
tion and NeuN for neuronal differentiation revealed newly generated cells that originate from Sox2+ precur-
sors in the adult cerebellum and express NeuN as a marker of granule neuron differentiation7 (Fig. 4a–e). We 
controlled for unspecific RFP expression by analysing Sox2-creERT2::tdTomato mice that received BrdU without 
Figure 2. Undifferentiated Sox2+ cells express stemness marker Nestin and show reactive properties. 
Undifferentiated Sox2+ cells are characterized by Nestin expression, detected by Nestin-dependent GFP 
expression and the lack of Blbp expression (a–c). Additionally, Sox2+ Nestin+ cells show proliferative capacity 
as shown by Ki67 labeling (d–f). Sox2+ S100− cells were sparsely distributed in the PCL of control animals (g–i) 
when compared to animals that received a week of physical training (arrows in j–l). Training of mice on the 
RotaRod system lead to a significant increase in the number of Sox2+ S100− cells within the PCL as compared 
to controls (m – Mann-Whitney-U test; SEM). Immunohistochemical staining in panels a – f was performed on 
4 µm FFPE sections. Staining shown in panels g – l was performed on 50 µm free-floating vibratome sections. 
White lines show perimeter of Purkinje cell layer. Scale bars equate to 50 µm in panels a – f and 100 µm in panels 
g – l.
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Tamoxifen injections. By using BrdU-expression as an inclusion criterion, we made sure to include only RFP 
and NeuN-positive cells that had undergone proliferation since injection, thus excluding any RFP-positive neu-
rons that may have been there since early development. Intriguingly, cerebellar neurogenesis was significantly 
enhanced by physical activity. The composition of the BrdU+ population within PCL and IGL of the adult mouse 
cerebellum is shown in Fig. 4f. We counted an average of 30 BrdU+ cells per mid-sagittal section. While there is 
no significant difference in the total BrdU+ population when comparing control and RotaRod mice, the BrdU+ 
population originating from Sox2 expressing cells (BrdU+ RFP+) and the BrdU+ population originating from 
Sox2 expressing cells that have differentiated into neurons (BrdU+ RFP+ NeuN+) increased significantly when 
comparing RotaRod to control mice. Mice that received physical training on a RotaRod also displayed a more 
than 3-fold increase in RFP+ NeuN+ cells from all BrdU+ cells in midsagittal cerebellar sections (p = 0.0357; 
Fig. 4g). It has been shown that physical activity can increase the rate, at which new neurons are generated from 
Sox2+ cells within the mature hippocampus 2. A similar trend could be observed after equivalent exposure to 
an enriched environment, where we also found an increase in BrdU+ RFP+ cells (31.4% control, 45.5% EE; 
p = 0.2286) and in BrdU+ RFP+ NeuN+ cells (5.1% control, 15.3% EE; p = 0.0571).
Finally, we detected a very small number of RFP+ BrdU+ cells within the internal granule cell layer of the 
cerebellum that expressed cFos, an immediate early gene that will result in production of an activity-dependent 
protein8, providing first evidence that cells that have been generated by Sox2 expressing progenitors may become 
integrated into the cellular network of the cerebellum (Fig. 4h–i). At this point the mother cell of these new born 
neurons can be described as Sox2+, therefore also as NeuN−, as these two markers exclude each other within the 
IGL of the adult cerebellum (Supplementary Figure 1a–c).
Since its initial discovery in 1962 the existence of adult neurogenesis has now been widely accepted and great 
progress has been made in the understanding of the process. Our data further improve this notion by identifying 
a so far unknown neurogenic niche in the mature cerebellum of adult mice. Further investigation will be neces-
sary to understand and to take advantage of this finding.
Figure 3. Reactivity of SOX2+ S100− cells in the human cerebellum. In human cerebellar tissue (a) 
we found SOX2+ S100− cells intermingled with the Bergmann glia of the Purkinje cell layer (arrows in 
b–d). Upon damage to the cerebellum by cerebellar infarcts, we observed reactive gliosis with massive 
expansion of the Bergmann glia (e) as well as expansion of SOX2+ S100− cells (f–i, standard t-testing; SEM). 
Immunohistochemical staining was performed on 4 µm FFPE sections. Scale bars in panels a and e equate to 
200 µm, scale bars for panels b – h equate to 50 µm.
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Figure 4. Neurogenesis from Sox2+ cells in the adult cerebellar cortex. Combined BrdU birth-dating and fate-
mapping experiments show RFP+ progeny from Sox2+ cells (a) that had incorporated BrdU during the observation 
period (b) and had also acquired neuronal differentiation as shown by staining for the granule cell marker NeuN (c). 
Nuclear DAPI staining is shown as a reference in panel d. A maximum intensity projection is shown in panel e with 
orthogonal views of x-z and y-z planes. The images have been taken after a treatment course with Tamoxifen and 
BrdU according to the scheme in Supplementary Figure 2. An increase in neurogenesis from Sox2+ cells could be 
achieved by physical activity. Mice that were trained on the RotaRod showed significantly more new-born granule 
neurons in the internal granule cell layer (IGL), when compared to control animals (f,g – Mann-Whitney-U test; 
SEM). RotaRod data were obtained after a Tamoxifen/BrdU treatment according to the scheme in Supplementary 
Figure 2. Possible integration of progeny from Sox2+ progenitors is shown by positive staining for the activity 
regulated transcription factor cFos (h–l). Immunohistochemical staining was performed on 50 µm free-floating 
vibratome sections. Scale bars for panels a – d and h – k equate to 40 µm, scale bars in panels e and l equate to 10 µm.
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Material and Methods
All experiments and methods, including those using human tissue samples, were carried out in accordance with 
relevant guidelines and regulations. All mouse experiments were approved by the local government of Upper 
Bavaria (Regierung von Oberbayern). Human samples were used in accordance with the guidelines and reg-
ulations of the local ethics committee. All patients had given their informed consent; all tissue samples were 
irreversibly anonymized.
Transgenic mice. Sox2-creERT2 mice9, hGFAP-cre mice10 and tdTomato reporter mice11 were obtained from 
the Jackson Laboratory. Nestin-GFP mice were used as previously described12. Genotyping was performed by PCR 
analysis using genomic DNA from ear biopsies. Primers for Cre13 and tdTomato14 have been published previously.
Human samples. Human samples were formalin-fixed and paraffin-embedded. Three cerebella without any 
clinical or neuropathological changes and three cerebella with infarcts in the cerebellum were immunohisto-
chemically stained and evaluated.
Tamoxifen-induction and BrdU pulse chase. Cre-ERT2 -dependent recombination in vivo induction 
of cre activity was achieved by intraperitoneal tamoxifen (Sigma-Aldrich) injection. Animals were injected with 
tamoxifen at 50 mg kg−1 body weight in corn oil (Sigma-Aldrich). BrdU was also injected intraperitoneally at 
50 mg kg−1 in saline solution. We established an injection protocol, where we start the course of tamoxifen injec-
tions one day before starting the BrdU injections to account for slower kinetics of Tamoxifen until it induces gene 
expression, while BrdU is incorporated into dividing cells within 2–4 h. Mice were injected with Tamoxifen for 
8 and with BrdU for 7 consecutive days and sacrificed after 2 additional days (Supplementary Figure 2a) for all 
analyses apart from cFos stainings, where mice were injected with Tamoxifen for 8 and BrdU for 7 consecutive 
days and sacrificed after 5 additional days and a final hour in the enriched environment setting (Supplementary 
Figure 2b).
RotaRod/Enriched environment. Adult Sox2-creERT2::tdTomato-mice (>60 days postpartum) were either 
trained on the RotaRod system (RotaRod advanced; TSE Systems, Bad Homburg, Germany) or placed in an 
enriched environment (EE) to study reactivity of progenitors and neurogenesis. The experimental scheme of the 
physical exercise paradigms is shown in Supplementary Figure 2. On the RotaRod, mice were trained twice daily 
for seven days, one run in the morning, one in the afternoon, after having received daily BrdU and tamoxifen 
injections prior to the first run. Each mouse had to complete 3 runs per session for at least 10 s (exclusion crite-
rion) and maximally 300 s. Progress in running times was monitored with the TSE RotaRod software. Enriched 
environment was performed as follows: Mice were placed in a large cage (cage size 42 × 23 × 19 cm) for 7 days 
with daily injections of BrdU and tamoxifen. The cage contained at least one running wheel, tunnels, ladders 
and shelter. These settings were changed every two days. For both experimental paradigms, control mice only 
received BrdU and tamoxifen injections and were then placed back into standard cages. Data from behavioural 
experiments were obtained from three separate litters that were trained in independent experimental rounds as 
soon as they were old enough.
Immunohistochemistry. Paraffin-embedded tissue was sectioned, deparaffinised, and rehydrated before 
heat-induced antigen retrieval was conducted at 100 °C for 20 min in 10 mM sodium citrate buffer (pH 6) for all 
antibodies. Immunohistochemical staining was done using primary antibodies (Sox2: 1:200, Abcam ab97959; 
GFP: 1:200, Santa Cruz sc-8334) and the HRP/DAB Staining System (DAKO) according to the manufacturer’s 
specifications. Hemalaun was used for nuclear counterstaining. All histological photomicrographs were taken 
digitally using an Olympus BX50 microscope in combination with the Color View Soft imaging system. For 
confocal imaging, brains were cut into 50 µm thick sections on a vibratome and stained free-floating. For stand-
ard microscopy, 4 µm thin sections were stained on slides. For immunofluorescent double- and triple-staining, 
sections were washed twice with 1% Triton X-100/PBS and then incubated in blocking buffer (10% normal goat 
serum in 1% Triton X-100/PBS) for 1 h. For BrdU staining, sections were additionally incubated in 2 N HCl 
and 0.1 M boric acid buffer (pH 8.5) for 10 min each prior to blocking. Primary antibodies (BrdU: 1:200, abcam 
ab6326; Blbp15: 1:5000; cFos: 1:200, Invitrogen 38–4950; Cre: 1:100, Covance PRB106C; GFP: 1:200, Santa Cruz 
sc-8334: 1:200; molecular probes A21311: 1:200; Ki67: 1:200, abcam ab16667; NeuN: 1:200, abcam ab128886 or 
ab104224; Olig2: 1:200, Millipore AB960; Parvalbumin: 1:200, Millipore AB15736; Pax2: 1:200, Zymed 71-6000; 
RFP: 1:200, antibodies online A234; S100: 1:2000, DAKO 4C4.9 or 1:200 abcam ab14849; Sox2: 1:200, abcam 
ab97959 or ab79351) were diluted in blocking buffer and applied over night at 4 °C. Next, tissue was washed twice 
with 1% Triton X-100/PBS and incubated for 1 h with a 1:500 dilution of Alexa-fluorophore conjugated secondary 
antibodies (goat anti-mouse Alexa488/Alexa555/Alexa647; goat anti-rabbit Alexa488/Alexa555/Alexa647, goat 
anti-rat Alexa647; Invitrogen) in blocking buffer. Sections were washed twice with PBS, counterstained with 
4′,6-diamidino-2-phenylindole (DAPI), and mounted in Fluorescent Mounting Medium (DAKO). All fluorescent 
images of tissue samples were obtained either on the Zeiss ApoTome.2 structured illumination system in combi-
nation with the Zen Blue software (Zeiss, 2012), the Zeiss LSM 780 in combination with the Zen Black software 
(Zeiss, 2011) or on an Olympus IX50 microscope in combination with the Color View Soft imaging system. All of 
the stains were repeated at least 3 times on tissue from the same sample and also in at least 3 independent subjects.
All images shown in the figures are representative and have been artificially coloured to colour-safe combina-
tions using Image J.
Quantification and Statistical analysis. Results were analysed using the Prism5 software (GraphPad). 
P-values < 0.05 were considered significant. The Mann–Whitney-U test was used to compare the median of 2 
groups. Standard t-testing was performed to compare groups with a Gaussian distribution of data according 
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to the central limit theorem. For behavioural experiments quantifications were performed blinded, meaning 
the investigator did not know whether the tissue analysed came from animals that had or had not undergone 
RotaRoad training or had or had not been housed in an enriched environment. For other evaluations and quan-
tifications, the investigator did not know which color represented which marker. Samples sizes are given in the 
appropriate figures where statistical analyses were performed. For qualitative and descriptive figures, we show 
representative images and analysed brain sections from at least five different animals and counted 300 cells per 
sections. For quantification of BrdU+ RFP+ NeuN+ cells and Sox+ S100− cells in Sox2-creERT2::tdTomato mice we 
analysed at least 6 entire midsagittal sections per mouse. To calculate the fraction of Sox2+ S100− cells, at least 500 
cells were counted for each human sample (control and cerebellar infarct). Results were analysed using the Fisher 
exact test. All respective histograms illustrate the standard error of the mean (SEM; error bars).
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